Clinical Trials Logo

Clinical Trial Summary

Indirect pulp capping (IPC) is a treatment that preserves pulp's vitality. Several materials have been used for this procedure. The aim of this study is to evaluate the radiographic and clinical outcomes of TheraCal LC (Bisco Inc., Schaumburg, IL, USA) and to compare it with mineral trioxide aggregate (MTA) (Pro Root MTA, Dentsply Tulsa, Johnson City, TN, USA) and calcium hydroxide [Ca(OH)2] (Dycal, Dentsply De Trey Konstanz, Germany) biomaterials in IPC treatment.


Clinical Trial Description

A total of 295 teeth, including second primary molars and first permanent molars with IPC indications from healthy and cooperative children between the ages of 4-15, were included in this study. Teeth were divided into three groups according to the materials used for pulp capping. Indirect pulp treatment was applied using Dycal for 91 teeth, ProRoot MTA for 89 teeth and TheraCal LC for 115 teeth. Primary molars were restored with the compomer material, and permanent molars were restored with the resin composite material. Restorations were evaluated with the Modified United States Public Health Service (modified USPHS) criteria. Clinical and radiographic findings were evaluated for 24 months at follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03606681
Study type Interventional
Source Altinbas University
Contact
Status Completed
Phase N/A
Start date July 2013
Completion date June 2015

See also
  Status Clinical Trial Phase
Completed NCT06402032 - Clinical and Histological Evaluation of Hesperidin as a Direct Pulp Capping Material N/A
Completed NCT02891876 - 3-months Success Rate of Direct Pulp Capping With Biodentine® N/A
Active, not recruiting NCT03403985 - Long-term Evaluation of Direct Pulp Capping N/A
Completed NCT02620826 - Prospective Comparison of Indirect Pulp Therapy and Mineral Trioxide Aggregate Pulpotomy in Decayed Primary Molars N/A